Evidence map›Paper›PMID 33553823›Full record

ArticleBioactive materials2021

Bioproduced Proteins On Demand (Bio-POD) in hydrogels using

Shuo-Fu Yuan, Sierra M Brooks, Annalee W Nguyen, Wen-Ling Lin, Trevor G Johnston, Jennifer A Maynard, Alshakim Nelson, Hal S Alper

Open access · goldAbstract read
In one paragraph

Article in Bioactive materials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Engineered Living Hydrogels.Advanced materials (Deerfield Beach, Fla.) · 2022
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shuo-Fu YuanInstitute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX, USA.
Sierra M BrooksMcKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
Annalee W NguyenMcKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
Wen-Ling LinInstitute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX, USA.
Trevor G JohnstonDepartment of Chemistry, University of Washington, Box 351700, Seattle, WA, USA.
Jennifer A MaynardMcKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
Alshakim NelsonDepartment of Chemistry, University of Washington, Box 351700, Seattle, WA, USA.
Hal S AlperInstitute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX, USA.
The University of Texas at Austin · USUniversity of Washington · US

Funding

3D Printed Engineered Living Materials for Drug DeliveryR21EB031256 · NIBIB · UNIVERSITY OF WASHINGTON · PI NELSON, ALSHAKIM · 2022 to 2024
$589k
NIBIB NIH HHS R21 EB031256
6 · The paper itself

Abstract

Traditional production of industrial and therapeutic proteins by eukaryotic cells typically requires large-scale fermentation capacity. As a result, these systems are not easily portable or reusable for on-demand protein production applications. In this study, we employ Bioproduced Proteins On Demand (Bio-POD), a F127-bisurethane methacrylate hydrogel-based technique that immobilizes engineered

Indexed as

HydrogelImmobilizationLyophilizationPichia pastorisProtein production

Identifiers

PMID33553823
PMCPMC7846901
OpenAlexW3128169317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.